New York, USA – June 27, 2022 – Liposomes are used as a delivery system for drugs, genes, and vaccines in therapeutics and have received much attention in the past few decades as pharmaceutical carriers of great potential. Research Nester has recently released a report on the “Global Liposome Drug Delivery Market,” which is a study for the forecast period, i.e., 2022-2031. In more detail, the global liposome drug delivery market generated a revenue of USD 4,356.7 million in 2021 and is further expected to reach USD 11,977.1 million by the end of 2031, growing at a CAGR of 10.69% during the forecast period.
In application, the relative concentration, size, and lamellar thickness of liposomes, lipid composition, and incubation temperature directly affect liposome stability. Therefore, the physical and chemical parameters of liposome formulation must be strictly monitored to ensure good reproducibility and functionality. Creative Biolabs has extensive experience in supporting liposomal formulation characterization, as well as release testing and stability program management for liposomal products.
Creative Biolabs’ liposomal product analysis and characterization services include:
• Lipid Bilayer Analysis
Lipid bilayer analysis and characterization matter in liposome research, seeing that the choice of lipids determines the characteristics of liposomes, including lamellarity and phase behavior in different environments. Creative Biolabs can present lamellarity data by means of ³¹P nuclear magnetic resonance (³¹P NMR), small-angle X-ray scattering (SAXS), and other measurement techniques based on changes in spectral signals. In addition to the micropipette method, spectral analysis of shape fluctuation, atomic force microscopy (AFM) and optical dynamometry, Creative Biolabs can monitor the characterization of phase behaviors during research.
• Encapsulated Drug Analysis
Liposome-formulated drugs present compelling advantages over unencapsulated drugs. In the developing process of liposome formulations, the analysis of drug encapsulation efficiency (EE) and in vitro release (IVR) profile is the basis for evaluating the liposome delivery system. Creative Biolabs can support encapsulated drug analysis by providing high-quality pharmaceutical and nutritional analytical laboratory and testing services with an emphasis on liposomal formulation EE and IVR analysis. First-rate analytical testing and qualitative services, in addition to the most reliable and consistent data analysis, can be provided at the most competitive price.
• Basic Characterization of Liposomes
Morphology and size are core characteristics of liposomes, which affect physical and chemical properties. The number of drugs that can be loaded into liposomes and the size of liposomes also play a key role in pharmacokinetic and pharmacodynamic properties. Creative Biolabs offers high-quality measurement services for liposomal particle size, accompanied by varieties of advanced characterization tools for basic characterization of liposomes, including size, zeta potential, morphology, and distribution.
Explore more information about Creative Biolabs’ liposome analysis and characterization services at https://www.creative-biolabs.com/lipid-based-delivery.
About Creative Biolabs
With more than ten years of experience in developing liposomal formulations, and a great team of experts and support staff, Creative Biolabs has successfully served thousands of customers all over the world, providing a full set of custom liposomal services and various liposomal products which exceed industry standards.
Media Contact
Company Name: Creative Biolabs
Contact Person: Candy Swift
Email: Send Email
Phone: 1-631-830-6441
Country: United States
Website: https://www.creative-biolabs.com/lipid-based-delivery
